rs137852912
|
|
|
0.740 |
GeneticVariation |
BEFREE |
We have hypothesized that transgenic Ossabaw swine expressing chimp <i>PCSK9</i> (proprotein convertase subtilisin-like/kexin type 9) containing the D374Y gain of function would develop familial hypercholesterolemia and coronary artery plaques more rapidly than Landrace swine with the same transgene.
|
29572319 |
2018 |
rs137852912
|
|
|
0.740 |
GeneticVariation |
BEFREE |
PCSK 9 gain-of-function mutations (R496W and D374Y) and clinical cardiovascular characteristics in a cohort of Turkish patients with familial hypercholesterolemia.
|
28777095 |
2017 |
rs137852912
|
|
|
0.740 |
GeneticVariation |
BEFREE |
We measured plasma PCSK9 concentrations in healthy men with a PCSK9 (proprotein convertase subtilisin/kexin type 9) loss-of-function variant (p.R46L), in statin-treated patients with a clinical diagnosis of familial hypercholesterolemia (FH) and carrying a PCSK9 gain-of-function mutation (p.D374Y), and in statin-treated patients with FH due to different genetic causes.
|
19797716 |
2009 |
rs137852912
|
|
|
0.740 |
GeneticVariation |
BEFREE |
We have identified the D374Y mutant of PCSK9 in three FH families of English origin; all 12 affected individuals have unusually severe hypercholesterolaemia and require more stringent treatment than typical FH patients, who are heterozygous for defects in the LDL receptor.
|
15772090 |
2005 |
rs137852912
|
|
C |
0.740 |
CausalMutation |
CLINVAR |
|
|
|
rs137852912
|
|
T |
0.740 |
GeneticVariation |
CLINVAR |
|
|
|
rs137852912
|
|
T |
0.740 |
CausalMutation |
CLINVAR |
|
|
|
rs564427867
|
|
|
0.720 |
GeneticVariation |
BEFREE |
Mean plasma total cholesterol (TC) (9.93 ± 2.95 mmol/L, mean ± SD) in true homo-FH cases with PCSK9 E32K or double hetero-FH cases with PCSK9 E32K and LDLR mutations were significantly lower than those in true homo-FH (18.06 ± 4.96 mmol/L) and compound heterozygous cases with LDLR mutations (14.84 ± 1.62 mmol/L).
|
25014035 |
2014 |
rs564427867
|
|
|
0.720 |
GeneticVariation |
BEFREE |
The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation.
|
20006333 |
2010 |
rs564427867
|
|
A |
0.720 |
CausalMutation |
CLINVAR |
|
|
|
rs564427867
|
|
A |
0.720 |
GeneticVariation |
CLINVAR |
|
|
|
rs374603772
|
|
|
0.710 |
GeneticVariation |
BEFREE |
This is the first study from a Turkish FH cohort, revealing a higher frequency (approximately 14%) of two PCSK9 GOF mutations (D374Y and R496W) and a different disease course compared to the world literature.
|
28777095 |
2017 |
rs374603772
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
|
|
|
rs1057519691
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA.
|
27998977 |
2017 |
rs793888521
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction.
|
26036859 |
2016 |
rs1057519691
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.
|
26374825 |
2015 |
rs185392267
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.
|
26374825 |
2015 |
rs1057519691
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol.
|
24115837 |
2013 |
rs1057519691
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia.
|
22683120 |
2012 |
rs1057519691
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs11583680
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1254346075
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1372204035
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs139669564
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs141502002
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|